People who suffer from coronary artery disease use to need Coronary artery bypass grafting (CABG) surgery, which commonly involves harvesting patients’ veins from the legs as grafts. This procedure may cause chronic pain and future complications, as more than 20% of implants fail after a year.
However, Xeltis has developed a project that can tackle this situation. HeartRestore is a unique vascular graft (XABG) that allows to naturally restore cardiac and vascular tissues, avoiding vein harvesting, repeated replacement procedures and long-term medication.
This device will bring a significant improvement for patients and healthcare systems, preventing future thrombosis and other adverse side effects frequently related to this cardiovascular disease.
